Biofrontera AG buy melinda
Start price
05.03.18
/
50%
€5.95
Target price
09.03.18
€6.40
Performance (%)
8.07%
End price
09.03.18
€6.43
Summary
This prediction ended on 09.03.18 with a price of €6.43. With a performance of 8.07%, the BUY prediction by melinda for Biofrontera AG closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biofrontera AG | - | - | - | - |
| iShares Core DAX® | -1.306% | -0.778% | 9.149% | 57.505% |
| iShares Nasdaq 100 | 1.979% | -2.045% | 6.569% | 90.022% |
| iShares Nikkei 225® | 0.593% | 6.713% | 31.580% | 65.481% |
| iShares S&P 500 | 1.425% | -0.477% | 3.616% | 62.099% |
According to melinda what are the pros and cons of Biofrontera AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Biofrontera AG diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Kalender 11/07 Generalversammlung
Biofrontera: Die Europäische Kommission genehmigt die Verwendung von Ameluz in Kombination mit der photodynamischen Therapie Tageslicht
5. März (Reuters) - Die Biofrontera AG :: PTA-ADHOC: Biofrontera AG: DIE EUROPÄISCHE KOMMISSION GENEHMIGT DEN EINSATZ IN KOMBINATION MIT Ameluz THERAPY Photodynamischen den Tag.
Stopped prediction by melinda for Biofrontera AG
Biofrontera AG
Start price
Target price
Perf. (%)
€1.60
06.12.21
06.12.21
€2.80
06.12.22
06.12.22
-1.25%
07.12.22
07.12.22
Could be worthwhile Investment >10% per year
Biofrontera AG
Start price
Target price
Perf. (%)
€3.16
17.03.20
17.03.20
€6.00
04.11.21
04.11.21
-25.32%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Biofrontera AG
Start price
Target price
Perf. (%)
€6.29
09.03.18
09.03.18
€8.00
14.03.18
14.03.18
13.99%
14.03.18
14.03.18
Could be worthwhile Investment >10% per year